Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Stroke

• Publication date

  2009-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/STROKEAHA.108.541128PMID 19246690PMCID PMC2888275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reprint: Good Laboratory Practice: Preventing Introduction of Bias at the Bench

  2009cited by this paper
• Methodological Quality of Animal Studies of Neuroprotective Agents Currently in Phase II/III Acute Ischemic Stroke Trials

  2009cited by this paper
• Empirical Evidence of Bias in the Design of Experimental Stroke Studies: A Metaepidemiologic Approach

  2008cited by this paper
• Optimal Definition for PWI/DWI Mismatch in Acute Ischemic Stroke Patients

  2008cited by this paper
• Plasticity of hippocampal stem/progenitor cells to enhance neurogenesis in response to kainate‐induced injury is lost by middle age

  2008cited by this paper
• Hypertension and cerebrovascular dysfunction.

  2008cited by this paper
• Evidence for the Efficacy of NXY-059 in Experimental Focal Cerebral Ischaemia Is Confounded by Study Quality

  2008cited by this paper
• A new penumbra: transitioning from injury into repair after stroke

  2008cited by this paper
• The clinical implications of ageing for rational drug therapy

  2008cited by this paper
• Stroke and TIA: epidemiology, risk factors, and the need for early intervention.

  2008cited by this paper
• Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications.

  2007cited by this paper
• Cell–cell Signaling in the Neurovascular Unit

  2007cited by this paper
• How can we improve the pre-clinical development of drugs for stroke?

  2007cited by this paper
• Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans?

  2007cited by this paper
• Rate, degree, and predictors of recovery from disability following ischemic stroke

  2007cited by this paper
• Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis.

  2007cited by this paper
• Hyperglycemia in Acute Ischemic Stroke: A Vascular Perspective

  2007cited by this paper
• Innovation through Global Collaboration: A New Source of Competitive Advantage

  2007cited by this paper
• A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke.

  2007cited by this paper
• NXY-059 for acute ischemic stroke.

  2006cited by this paper
• Bench to Bedside: The Quest for Quality in Experimental Stroke Research

  2006cited by this paper
• Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease.

  2006cited by this paper
• A new model of thromboembolic stroke in the posterior circulation of the rat.

  2006cited by this paper
• NXY-059 for acute ischemic stroke.

  2006cited by this paper
• 1,026 Experimental treatments in acute stroke

  2006cited by this paper
• Adult or Perinatal Brain Injury: Does Sex Matter?

  2005cited by this paper
• Systematic review and metaanalysis of the efficacy of FK 506 in experimental stroke

  2005cited by this paper
• Systematic Review and Metaanalysis of the Efficacy of FK506 in Experimental Stroke

  2005cited by this paper
• Improving the quality of reporting in randomised controlled trials.

  2004cited by this paper
• Functional and histological evidence for the protective effect of NXY-059 in a primate model of stroke when given 4 hours after occlusion.

  2003cited by this paper
• Long-Lasting Functional Disabilities in Middle-Aged Rats with Small Cerebral Infarcts

  2003cited by this paper
• Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial

  2002cited by this paper
• Polymorphism in Soluble Epoxide Hydrolase and Blood Pressure in Spontaneously Hypertensive Rats

  2002cited by this paper
• The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration

  2001cited by this paper
• Reversal of acute apparent diffusion coefficient abnormalities and delayed neuronal death following transient focal cerebral ischemia in rats

  1999cited by this paper
• Recommendations for standards regarding preclinical neuroprotective and restorative drug development.

  1999cited by this paper
• Potential effects of common drugs on stroke recovery.

  1998cited by this paper
• Perfusion Deficit Parallels Exacerbation of Cerebral Ischemia/Reperfusion Injury in Hyperglycemic Rats

  1997cited by this paper
• Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

  1996cited by this paper
• The CONSORT Statement

  1996cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper
• The evolution of acute stroke recorded by multimodal magnetic resonance imaging.

  1993cited by this paper
• Tissue plasminogen activator reduces neurological damage after cerebral embolism.

  1985cited by this paper

• Therapeutic value of mesenchymal stem cell-derived extracellular vesicles in hypertrophic and keloid scars: a systematic review and meta-analysis

  2026cites this paper
• Regulating the Impact of Hypertension on Stroke: Therapeutic Potential of a Peptide Mimetic of Tyrosine Phosphatase STEP.

  2026cites this paper
• A systematic review and meta-analysis assessing the influence of histone deacetylase 6 inhibition on brain infarction and neurological function following acute ischaemic stroke in rodent models

  2026influential citation
• Impact of Oxidized Phospholipids on Outcomes from Cerebral Ischemia and Reperfusion Injury.

  2026cites this paper
• The phoenixin-14/GPR173 Axis enhances post-stroke angiogenesis through ETS1-mediated VEGF signaling.

  2026cites this paper
• Exploring the neuroprotective effects of phytocannabinoids on oxygen-glucose deprived neurons in an in vitro model of stroke

  2026cites this paper
• Neutralizing XCL1 Attenuates Brain Injury and Reduces Lymphocyte and Dendritic Cell Recruitment Following Intracerebral Hemorrhage in Mice

  2025cites this paper
• Nanoparticles for Thrombolytic Therapy in Ischemic Stroke: A Systematic Review and Meta-Analysis of Preclinical Studies

  2025cites this paper
• Extracellular Vesicles from Poor-Outcome Intracerebral Hemorrhage Patients Reveal Limited Reparative Potential in a Preclinical Model

  2025cites this paper
• Role of histone deacetylases and sirtuins in the ischaemic stroke: a systematic review and meta-analysis of animal studies

  2025cites this paper
• Integrating in silico and experimental approaches to uncover the anti-apoptotic effects of anhydrosafflor yellow B via JNK/Bid pathway in ischemic stroke.

  2025cites this paper
• Preclinical Ischemic Stroke Multicenter (PRISM) Trials Collective Statement: Opportunities, Challenges, and Recommendations for a New Era.

  2025cites this paper
• Stroke: Current State of the Problem

  2025cites this paper
• Retrograde transport of neurotrophin receptor TrkB-FL induced by excitotoxicity regulates Golgi stability and is a target for stroke neuroprotection

  2025cites this paper
• Differential Expression of Circular RNAs in the Frontal Cortex of the Rat Brain in Ischemia–Reperfusion

  2025cites this paper
• Preparation and characterization of a modified nimodipine injection: an in vitro and in vivo study

  2025cites this paper
• Therapeutic potential of natural products in ischemic stroke: targeting angiogenesis

  2025cites this paper
• Veterinary medical care in rodent models of stroke: Pitfalls and refinements to balance quality of science and animal welfare.

  2025cites this paper
• The Anti-Parkinsonian A2A Receptor Antagonist Istradefylline (KW-6002) Attenuates Behavioral Abnormalities, Neuroinflammation, and Neurodegeneration in Cerebral Ischemia: An Adenosinergic Signaling Link Between Stroke and Parkinson’s Disease

  2025cites this paper
• The role of correlated colour temperature in myopia development and prevention

  2025cites this paper
• MicroRNA-29a-5p attenuates hemorrhagic transformation and improves outcomes after mechanical reperfusion for acute ischemic stroke

  2025cites this paper
• AX-024 Inhibits Antigen-Specific T-Cell Response and Improves Intracerebral Hemorrhage Outcomes in Mice

  2025cites this paper
• Behavioral assessment of neuropsychiatric outcomes in rodent stroke models

  2025cites this paper
• Acute Treatment with Salvianolic Acid A Produces Neuroprotection in Stroke Models by Inducing Excitatory Long-Term Synaptic Depression.

  2025cites this paper
• Intraperitoneal administration of NMDA-Subunit NR1-receptor antibodies does not improve long-term outcome in a murine MCAo-stroke model

  2025cites this paper
• ISQ201, a neuroprotective agent in ischemic stroke, is a novel activator of protein synthesis via allosteric binding to translation factor eIF4E.

  2025cites this paper
• Prophylactic PDE4 and PDE4B inhibition reduce lesion size and neutrophil infiltration following ischemic stroke in male mice.

  2025cites this paper
• Comparing Neuroprotective Drug Efficacy in Rodent Neonatal Brain Injury Models

  2025cites this paper
• Post-stroke seizures in animal models: a systematic review and meta-analysis

  2025cites this paper
• Preclinical Use of Group I Metabotropic Glutamate Receptors (Group I mGluRs) for Ischemic Stroke: Systematic Review and Meta-Analysis

  2025cites this paper
• Recombinant Irisin Therapy Alters Brain Transcriptome and Protects Against Ischemic Damage in Middle-Aged Rats.

  2025cites this paper
• Spatial and Temporal Assessment of Cerebral Blood Flow in a Novel Piglet Model of Neonatal Arterial Ischemic Stroke

  2025cites this paper
• Neuroprotective role of carvacrol in ischemic brain injury: a systematic review of preclinical evidence and proposed TRPM7 involvement

  2025cites this paper
• Effect of acupuncture on brain microenvironment in rats with post-stroke limb spasticity based on single-cell transcriptome sequencing technology.

  2025cites this paper
• Spatial frequency of environments and myopia: A systematic review on associated evidence and underlying mechanisms

  2025cites this paper
• Governor vessel acupuncture therapy in experimental ischemic stroke: A systematic review and meta-analysis

  2025cites this paper
• A Systematic Review on Neuroprotective Effects of Catalpol in Acute Focal Ischemic Stroke and their Possible Mechanisms

  2025cites this paper
• Intermittent hypoxic perconditioning improves cognitive function in a mouse model of vascular cognitive impairment and dementia with comorbidities by recovering cerebral blood flow.

  2025cites this paper
• Ovarian Hormones and Addictive Behaviour Vulnerability: Insights From Preclinical Studies

  2025cites this paper
• Uric Acid Stroke Cerebroprotection Transcended Sex, Age, and Comorbidities in a Multicenter Preclinical Trial

  2025cites this paper
• Motor impairment and adaptation in a novel non-human primate model of internal capsule infarct

  2025cites this paper
• Therapeutic hypothermia for acute ischemic stroke: from preclinical studies to clinical trials

  2025cites this paper
• Imatinib attenuates neurobehavioral deficits and hippocampal neuronal damage after global cerebral ischemia in gerbils

  2025cites this paper
• Recanalization and reperfusion in clinically-relevant porcine model of stroke

  2025cites this paper
• How to Pick a Neuroprotective Drug in Stroke Without Losing Your Mind?

  2025cites this paper
• Combination of alpha-1 antitrypsin (A1AT) and anti-TNFα as a neuroprotective strategy in the early stages after ischemic stroke

  2025cites this paper
• Proteomics of In Vivo Models of Ischemic Stroke: A Systematic Review with a Systems Biological Perspective.

  2025cites this paper
• Genetic deletion of microRNA-15a/16-1 in pericytes stimulates cerebral angiogenesis and promotes functional recovery after ischemic stroke

  2025cites this paper
• Hydrogels for regulating the pathological microenvironment in ischemic stroke: Emerging strategies and future perspectives

  2025cites this paper
• Signatures of covert neuron loss in the local field potential of motor cortex

  2025cites this paper
• Behavioral tests to assess short- and long-lasting sensorimotor deficits following transient focal cerebral ischemia in rodents

  2025cites this paper
• The vascular-immune-neural network: a new pathophysiological paradigm and the dawn of cytoprotection in stroke

  2025cites this paper
• Most prominent challenges in translational neuroscience and strategic solutions to bridge the gaps: Perspectives from an editorial board interrogation

  2025cites this paper
• Preclinical Evidence of Nogo-A Inhibition in Stroke Recovery: A Scoping Review.

  2025cites this paper
• A Systematic Review of Depth-Dependent Cytoprotection with Therapeutic Hypothermia for Cerebral Ischemia

  2025cites this paper
• Ranolazine neuroprotection against middle cerebral artery occlusion/reperfusion ischemic injury via modulation of brain-derived neurotrophic factor and brain mitochondrial tu translation elongation factor (TUFM)

  2025cites this paper
• Adeno-associated virus-mediated inhibition of ROCK2 promotes synaptogenesis and neurogenesis in rats after ischemic stroke.

  2025cites this paper
• Neurological recovery after ICH is mediated by the aryl hydrocarbon receptor-bilirubin interplay through improved erythrophagocytosis

  2025cites this paper
• Targeted Intestinal Cooling Offers Superior Brain Protection in the Mouse Stroke Model

  2025influential citation
• Acute-Phase Recording of the Spreading Depolarization Continuum in Aged Nonhuman Primates During Focal Ischemic Stroke

  2025cites this paper
• Animal models in tuberculosis metabolomics: a systematic review of current evidence and the road to translational relevance

  2025cites this paper
• Effects of different reperfusion durations on neuronal mitochondrial ultrastructure following cerebral ischemia in diabetic rats: a transmission electron microscopy study

  2025cites this paper
• Preclinical systematic review of CCR5 antagonists as cerebroprotective and stroke recovery enhancing agents

  2025influential citation
• Recombinant GDF11 Promotes Recovery in a Rat Permanent Ischemia Model of Subacute Stroke

  2025cites this paper
• Incidence and characterization of spontaneous pituitary neuroendocrine tumors in aged spontaneously hypertensive rats

  2025cites this paper
• The temporal dynamic of bradykinin type 2 receptor effects reveals its neuroprotective role in the chronic phase of cerebral and retinal ischemic injury

  2024cites this paper
• Adipose stem cell-derived exosomes in the treatment of wound healing in preclinical animal models: a meta-analysis

  2024cites this paper
• S100A9 deletion in microglia/macrophages ameliorates brain injury through the STAT6/PPARγ pathway in ischemic stroke

  2024cites this paper
• Preclinical assessment for translation to humans: The PATH approach for assessing supporting evidence for early-phase trials and innovative care.

  2024cites this paper
• Aberrant blood-brain barrier dynamics in cerebral small vessel disease - a review of associations, pathomechanisms and therapeutic potentials

  2024cites this paper
• Long noncoding RNA H19 knockdown promotes angiogenesis via IMP2 after ischemic stroke

  2024cites this paper
• Effects of Vibration on Accelerating Orthodontic Tooth Movement in Clinical and In Vivo Studies: A Systematic Review

  2024cites this paper
• Comparative Brain Proteomic Analysis between Sham and Cerebral Ischemia Experimental Groups

  2024cites this paper
• Emerging Roles of Exosomes in Stroke Therapy

  2024cites this paper
• Targeting TNF-α: The therapeutic potential of certolizumab pegol in the early period of cerebral ischemia reperfusion injury in mice.

  2024cites this paper
• Stroke Studies in Large Animals: Prospects of Mitochondrial Transplantation and Enhancing Efficiency using Hydrogels and Nanoparticle-assisted Delivery.

  2024cites this paper
• The impact of experimental diabetes on intracerebral haemorrhage. A preclinical study.

  2024cites this paper
• A meta-analysis of animal studies evaluating the effect of hydrogen sulfide on ischemic stroke: is the preclinical evidence sufficient to move forward?

  2024cites this paper
• Abolishing UCHL1’s hydrolase activity exacerbates ischemia-induced axonal injury and functional deficits in mice

  2024cites this paper
• A dispensable role of mural cell-derived laminin-α5 in intracerebral hemorrhage

  2024cites this paper
• Lipid engineered nanomaterials: A novel paradigm shift for combating stroke

  2024cites this paper
• NK1 tachykinin receptor antagonist treatment reduces cerebral edema and intracranial pressure in an ovine model of ischemic stroke

  2024cites this paper
• Review: Preclinical Models of Large‐Vessel Occlusion Stroke

  2024cites this paper
• Secondary Ischemia Assessment in Murine and Rat Preclinical Subarachnoid Hemorrhage Models: A Systematic Review

  2024cites this paper
• Inhibition of OGFOD1 by FG4592 confers neuroprotection by activating unfolded protein response and autophagy after ischemic stroke

  2024cites this paper
• The Effects of IRL-1620 in Post-ischemic Brain Injury: A Systematic Review and Meta-analysis of Experimental Studies

  2024cites this paper
• Neuroprotective effects of exosomes derived from bone marrow mesenchymal stem cells treated by Musk Ketone on ischemic stroke rats.

  2024cites this paper
• Role of histone deacetylases and sirtuins in the ischaemic stroke: a protocol for a systematic review and meta-analysis of animal studies

  2024cites this paper
• Dl-3-n-Butylphthalide Alleviates Secondary Brain Damage and Improves Working Memory After Stroke in Cynomolgus Monkeys

  2024cites this paper
• The Neuroprotective Effect of Therapeutic Hypothermia in Cognitive Impairment of an Ischemia/Reperfusion Injury Mouse Model

  2024cites this paper
• Hi1a Improves Sensorimotor Deficit following Endothelin-1-Induced Stroke in Rats but Does Not Improve Functional Outcomes following Filament-Induced Stroke in Mice.

  2024cites this paper
• Unscheduled changes in pre-clinical stroke model housing contributes to variance in physiological and behavioural data outcomes: A post hoc analysis

  2024cites this paper
• The case for neuregulin-1 as a clinical treatment for stroke

  2024cites this paper
• Anti-aging effect of peptides on Caenorhabditis elegans: a meta-analysis.

  2024cites this paper
• Prevalence of Arm Weakness, Pre-Stroke Outcomes and Other Post-Stroke Impairments Using Routinely Collected Clinical Data on an Acute Stroke Unit

  2024cites this paper
• NCAM mimetic peptide P2 synergizes with bone marrow mesenchymal stem cells in promoting functional recovery after stroke

  2024cites this paper
• MANF protein expression is upregulated in immune cells in the ischemic human brain and systemic recombinant MANF delivery in rat ischemic stroke model demonstrates anti-inflammatory effects

  2024cites this paper
• Brain FADE syndrome: the final common pathway of chronic inflammation in neurological disease

  2024cites this paper
• A dispensable role of oligodendrocyte-derived laminin-α5 in brain homeostasis and intracerebral hemorrhage

  2024cites this paper
• The Cell Permeant Phosphopetpide mimetic of VASP Alleviates Motor Function Deficits After Experimental Subarachnoid Hemorrhage

  2024cites this paper